These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 31504570)

  • 21. Drug-induced thrombocytopenia: an updated systematic review, 2008.
    Swisher KK; Li X; Vesely SK; George JN
    Drug Saf; 2009; 32(1):85-6. PubMed ID: 19132808
    [No Abstract]   [Full Text] [Related]  

  • 22. Does the conventional dosage of linezolid necessitate therapeutic drug monitoring?-Experience from a prospective observational study.
    Fang J; Chen C; Wu Y; Zhang M; Zhang Y; Shi G; Yao Y; Chen H; Bian X
    Ann Transl Med; 2020 Apr; 8(7):493. PubMed ID: 32395537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics.
    Rao GG; Konicki R; Cattaneo D; Alffenaar JW; Marriott DJE; Neely M;
    Ther Drug Monit; 2020 Feb; 42(1):83-92. PubMed ID: 31652190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosage regimen and toxicity risk assessment of linezolid in sepsis patients.
    Dou L; Meng D; Dong Y; Chen L; Han X; Fan D; Dong H
    Int J Infect Dis; 2020 Jul; 96():105-111. PubMed ID: 32251797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper
    Abdul-Aziz MH; Alffenaar JC; Bassetti M; Bracht H; Dimopoulos G; Marriott D; Neely MN; Paiva JA; Pea F; Sjovall F; Timsit JF; Udy AA; Wicha SG; Zeitlinger M; De Waele JJ; Roberts JA; ; ; ;
    Intensive Care Med; 2020 Jun; 46(6):1127-1153. PubMed ID: 32383061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of high plasma concentrations of linezolid in Taiwanese adult patients- therapeutic drug monitoring in improving adverse drug reactions.
    Cheng CN; Wu CC; Kuo CH; Wang CC; Wang JT; Lin YT; Jhang RS; Lin SW
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):466-475. PubMed ID: 32600864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment.
    Kim HY; Srivastava S; Ak HK; Marais BJ; Alffenaar JW
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366715
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of clindamycin compared with amoxicillin-metronidazole after a 7-day regimen in the treatment of periodontitis in patients with diabetes: a randomized clinical trial.
    Gómez-Sandoval JR; Robles-Cervantes JA; Hernández-González SO; Espinel-Bermudez MC; Mariaud-Schmidt R; Martínez-Rodríguez V; Morgado-Castillo KC; Mercado-Sesma AR
    BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial.
    Abdulla A; Ewoldt TMJ; Hunfeld NGM; Muller AE; Rietdijk WJR; Polinder S; van Gelder T; Endeman H; Koch BCP
    BMC Infect Dis; 2020 Jan; 20(1):57. PubMed ID: 31952493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factor analysis for linezolid-associated thrombocytopenia in critically ill patients.
    Cazavet J; Bounes FV; Ruiz S; Seguin T; Crognier L; Rouget A; Fourcade O; Minville V; Conil JM; Georges B
    Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):527-538. PubMed ID: 31853741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients.
    Kawasuji H; Tsuji Y; Ogami C; Kimoto K; Ueno A; Miyajima Y; Kawago K; Sakamaki I; Yamamoto Y
    BMC Pharmacol Toxicol; 2021 Mar; 22(1):13. PubMed ID: 33663616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients.
    Kawasuji H; Tsuji Y; Ogami C; Kaneda M; Murai Y; Kimoto K; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y
    Antibiotics (Basel); 2021 Apr; 10(5):. PubMed ID: 33925912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variable linezolid exposure and response and the role of therapeutic drug monitoring: Case series.
    Alghamdi WA; Al-Shaer MH; Klinker KP; Peloquin CA
    Clin Case Rep; 2020 Jul; 8(7):1126-1129. PubMed ID: 32695341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients: A Call for Action?
    Cattaneo D; Fusi M; Cozzi V; Baldelli S; Bonini I; Gervasoni C; Clementi E
    Clin Pharmacokinet; 2021 May; 60(5):603-609. PubMed ID: 33180272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population Pharmacokinetics and Dosage Optimization of Linezolid in Patients with Liver Dysfunction.
    Zhang SH; Zhu ZY; Chen Z; Li Y; Zou Y; Yan M; Xu Y; Wang F; Liu MZ; Zhang M; Zhang BK
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32253210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of Linezolid Dose Adjustment for Creatinine Clearance in Critically Ill Patients: A Multicenter, Prospective, Open-Label, Observational Study.
    Wang X; Wang Y; Yao F; Chen S; Hou Y; Zheng Z; Luo J; Qiu B; Li Z; Wang Y; Wu Z; Lan J; Chen C
    Drug Des Devel Ther; 2021; 15():2129-2141. PubMed ID: 34040351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosage Individualization of Linezolid: Precision Dosing of Linezolid To Optimize Efficacy and Minimize Toxicity.
    Luque S; Hope W; Sorli L; Muñoz-Bermudez R; Campillo N; Barceló-Vidal J; Álvarez-Lerma F; Horcajada JP; Masclans-Enviz JR; Neely M; Grau S
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33820765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging therapeutic drug monitoring of anti-infective agents in Australian hospitals: Availability, performance and barriers to implementation.
    Sandaradura I; Alffenaar JW; Cotta MO; Daveson K; Day RO; Van Hal S; Lau C; Marriott DJE; Penm J; Roberts JA; Tabah A; Williams P; Imani S
    Br J Clin Pharmacol; 2022 Feb; 88(2):669-679. PubMed ID: 34289135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment Analysis.
    Alghamdi WA; Al-Shaer MH; An G; Alsultan A; Kipiani M; Barbakadze K; Mikiashvili L; Ashkin D; Griffith DE; Cegielski JP; Kempker RR; Peloquin CA
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32778547
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.